Integer Holdings Corporation News
4 articles
growth-positive
InspireMD Launches CGuard Prime Carotid Stent System in the U.S.
InspireMD, Inc. has launched its CGuard Prime Carotid Stent System in the U.S. after receiving FDA premarket application approval. This launch is a significant milestone for the company, as it introduces its advanced stroke prevention technology to the U.S. market. The CGuard Prime system, featuring proprietary MicroNet mesh technology, aims to provide sustained embolic protection and reduce stroke risks. Despite a recent decline in share prices, the launch is expected to drive revenue growth and expand market share. InspireMDs market capitalization stands at $74.4 million, and the company is well-positioned to capture a significant portion of the U.S. carotid stenting market.
Product StageFDA approved/pending approval
growth-positive
NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
Novocure recently announced positive results from its Phase 3 PANOVA-3 trial, which evaluated the efficacy of Tumor Treating Fields (TTFields) therapy combined with gemcitabine and nab-paclitaxel for treating unresectable, locally advanced pancreatic cancer. The trial met its primary endpoint, showing a significant improvement in overall survival compared to standard chemotherapy. These results support the potential expansion of TTFields therapy beyond glioblastoma and mesothelioma, potentially leading to regulatory submissions in major markets. Despite a recent decline in share price, the positive trial outcomes could enhance Novocures long-term business prospects by enabling entry into the pancreatic cancer market, driving revenue growth, and improving reimbursement prospects.
Product Stage
Growth-Negative
"שיקוף של מצב הסטארט-אפים בתחום": אינטג'ר יוצאת מישראל
American medical equipment company Integer Holdings Corporation is closing its Israeli development center and laying off its 35 employees. The center, managed by Eyal Sandetz, was based on the acquisition of the Israeli Inomec in early 2020, and it will cease to exist in three weeks.
Layoffs
growth-positive
Integer buys Israeli medical device co Inomec
US medical device outsource manufacturer Integer Holdings Corporation has acquired Israeli medical device developer Inomec. The acquisition will allow Integer to set up an R&D and sales center in Israel, adding important catheter design, clinical, and pilot manufacturing capabilities to its portfolio. Inomec specializes in R&D and manufacturing medical devices, including minimally invasive tools, delivery systems, metal implants, drug-device combination devices, and laser processing services. The new center will enable Integer to be surrounded by an extensive pipeline of early and late stage startups as well as multinational medtech companies located in Israel.
AcquisitionExpand
